Table 4.
Factor | Value | Melanoma-specific survival | Recurrence-free survival | ||||
---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | ||
Managementa | Observation | 0.94 | 0.56–1.60 | 0.83 | 1.07 | 0.74–1.54 | 0.73 |
Sex | Male | 1.42 | 1.12–1.80 | 0.004 | 1.25 | 1.05–1.49 | 0.01 |
Age | Per year | 1.01 | 0.997–1.01 | 0.20 | 1.01 | 1.00–1.01 | 0.004 |
Melanoma location (reference: head and neck) | Upper limb | 0.72 | 0.52–0.99 | 0.045 | 0.81 | 0.64–1.03 | 0.09 |
Lower limb | 0.84 | 0.61–1.15 | 0.27 | 0.98 | 0.78–1.25 | 0.89 | |
Trunk | 0.94 | 0.70–1.14 | 0.65 | 0.72 | 0.57–0.91 | 0.005 | |
Breslow thickness, mm (reference: 0–1 mm) | 1.01–2 | 1.66 | 0.88–3.12 | 0.12 | 1.42 | 0.95–2.13 | 0.09 |
2.01–4 | 3.14 | 1.67–5.89 | < 0.001 | 2.46 | 1.63–3.69 | < 0.001 | |
> 4 | 5.38 | 2.83–10.24 | < 0.001 | 3.69 | 2.42–5.64 | < 0.001 | |
Tumor mitotic rate (reference: 0) | ≥ 1 | 2.91 | 1.36–6.22 | 0.006 | 1.98 | 1.26–3.13 | 0.003 |
Ulceration | Present | 1.71 | 1.37–2.13 | < 0.001 | 1.62 | 1.36–1.92 | < 0.001 |
HR hazard ratio, CI confidence interval
aSentinel node biopsy versus observation